I look forward to working with GenomeQuest as we all prepare to enter and contribute to a new, exciting age of discovery for human health and disease.
Westborough, MA (Vocus) September 21, 2010
GenomeQuest, a global leader in sequence data management, today announced the appointment of Richard K. Wilson, Ph.D., Professor of Genetics and Director of The Genome Center at Washington University School of Medicine, to its Science Advisory Board (SAB).
Richard Resnick, GenomeQuest Acting CEO, comments, "Rick is at the forefront of genome analysis and his lab is one of three NIH funded large-scale sequencing centers in the US. He will clearly bring GenomeQuest invaluable scientific insight on how researchers can make the most sense of the growing collection of genomic data. Also, from his combined vantage point at The Genome Center and as a leader at a comprehensive care center, he can offer guidance on how and where our technology and skills bring the most value to the full spectrum of the health care industry."
Dr. Wilson comments, "I was drawn to GenomeQuest first by the quality of the people. They have built a strong management team and are assembling a world-class scientific advisory board. I am also compelled by their ideas and technology—in particular for whole- and multi-genome analysis. I look forward to working with GenomeQuest as we all prepare to enter and contribute to a new, exciting age of discovery for human health and disease."
In an initial assignment, Dr. Wilson will be briefing pharmaceutical executives on personalized medicine for cancer at the fall GQ-PMR workshop in Cambridge, MA. He will be joined by Dr. Mark Boguski of Beth Israel Deaconess Medical Center, appointed to GenomeQuest’s SAB last year.
About Richard Wilson
Dr. Richard K. Wilson is an expert in molecular genetics and large-scale DNA sequence analysis, and his laboratory at the Washington University School of Medicine is a world leader in genome analysis. The laboratory was the first to sequence the genome of a cancer patient and discover genetic signatures relevant to the pathogenesis of the disease. Their current focus is to utilize genome sequencing and analysis technology to discover clues that can improve diagnosis and treatment of cancer and other human diseases. Dr. Wilson is Professor of Genetics and Molecular Microbiology, and a member of the Senior Leadership Team at the Siteman Cancer Center. He received his Ph.D. from the University of Oklahoma in Chemistry and Biochemistry and was a Research Fellow in the Division of Biology at the California Institute of Technology.
About the Genome Center
The Genome Center at Washington University School of Medicine is a world leader in the fast-paced, constantly changing field of genomics. The Center is pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.
About the Siteman Cancer Center
The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is an international leader in cancer treatment, research, prevention, education and community outreach. U.S. News & World Report magazine consistently rank their parent institutions -- Barnes-Jewish Hospital and Washington University School of Medicine -- among the best in the country.
About the GQ-PMR Program
GQ-PMR is a program for pharmaceutical firms to accelerate their transition to molecular-based, personalized medicine research (PMR). Its initial phase offers members a single, continuous database of aggregated public genetic datasets so that research teams can query and use this growing, global collection of sequence, variations, and annotation data in their day-to-day research.
GenomeQuest, the global leader in sequence data management, helps genomic researchers and their organizations make great discoveries far faster. Over 160 leading life science companies use GenomeQuest for mission-critical work, including nine of the top ten pharmaceuticals.
The GenomeQuest SDM platform enables researchers to analyze and manage sequence data from their web browser. Bioinformatics managers can customize applications and unify their sequence data environment. IT and business managers can efficiently scale genomics across discovery operations. The core technology of the platform is the GQ-Engine -- a database engine that is purpose-built for storing, analyzing, and managing sequence data at whole- and multi-genome scale.